Its name is derived from Beelzebub, Greek for "devil," and bufo, Latin for toad. Ampinga means "armored," describing the prominent cranial shield the species had on its head. The presence of ...

Using a native predator (the meat ant, Iridomyrmex reburrus) to reduce the abundance of an invasive species (the cane toad, Bufo marinus) in tropical Australia ...

Marine toads Bufo alvarius and Bufo marinus also have glands that secrete a viscous milky-white venom, which researchers say ...

Located in the town centre of Sarina, about 35km south of Mackay, locals nicknamed the landmark Buffy after the cane toad’s scientific name, Bufo Marinus. Buffy the canetoad sculpture in Sarina.

Next to the loss of habitat, alien invasion—the introduction and spread of species not indigenous to a location—is the leading cause of species endangerment and extinction. Here, read about ...

Marinus Pharmaceuticals MRNS is a micro-cap pharmaceutical stock with multiple Wall Street analysts seeing significant upside. Both Oppenheimer and Cantor Fitzgerald recently issued or reiterated ...

Cantor Fitzgerald analyst Charles Duncan lowered the firm’s price target on Marinus Pharmaceuticals (MRNS) to $4 from $13 and keeps an Overweight rating on the shares. The company’s Phase III ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today ...

The Marinus Smith Award recognizes faculty and staff members who have had a particularly positive impact on our students. Honorees are nominated by those they teach, mentor, support and serve. In New ...

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate ...

RADNOR, Pa., October 15, 2024--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...